scispace - formally typeset
R

Rob M. van Dam

Researcher at National University of Singapore

Publications -  401
Citations -  46736

Rob M. van Dam is an academic researcher from National University of Singapore. The author has contributed to research in topics: Population & Type 2 diabetes. The author has an hindex of 99, co-authored 362 publications receiving 38939 citations. Previous affiliations of Rob M. van Dam include University Health System & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

Andrew P. Morris, +232 more
- 01 Sep 2012 - 
TL;DR: This article conducted a meta-analysis of genetic variants on the Metabochip, including 34,840 cases and 114,981 controls, overwhelmingly of European descent, and identified ten previously unreported T2D susceptibility loci, including two showing sex-differentiated association.
Journal ArticleDOI

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

Benjamin F. Voight, +183 more
- 01 Jul 2010 - 
TL;DR: By combining genome-wide association data from 8,130 individuals with type 2 diabetes and 38,987 controls of European descent and following up previously unidentified meta-analysis signals, 12 new T2D association signals are identified with combined P < 5 × 10−8.
Journal ArticleDOI

Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries

Mary F. Feitosa, +299 more
- 18 Jun 2018 - 
TL;DR: In insights into the role of alcohol consumption in the genetic architecture of hypertension, a large two-stage investigation incorporating joint testing of main genetic effects and single nucleotide variant (SNV)-alcohol consumption interactions is conducted.
Journal ArticleDOI

Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data

TL;DR: Intensive insulin therapy significantly increased the risk of hypoglycemia and conferred no overall mortality benefit among critically ill patients, but this therapy may be beneficial to patients admitted to a surgical ICU.
Journal ArticleDOI

Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture

TL;DR: An association between both type 1 and type 2 diabetes and increased risk of hip fracture in men and women and between studies conducted in the United States and Europe is supported.